Neozene, Inc

US Right to Know is a prominent anti-biotech advocacy group based in Oakland, CA. Established in 2014 with seed money from the Organic Consumers Association, the organization focuses on public health and biotech-related topics. Known for filing Freedom of Information requests, US Right to Know aims to acquire emails of researchers and science writers to expose alleged collusion between the scientific community and biotech companies to hide the risks of their products. However, these accusations have been proven incorrect. There is evidence suggesting that US Right to Know has collaborated with Russian state-funded media outlets to spread misinformation about the safety of GMOs and agricultural chemicals. The organization has an annual revenue of $360,885 and total assets of $47,829 as of 2017. Major donors include the Organic Consumers Association, Laura and John Arnold Foundation, Dr. Bronner's Family Foundation, CrossFit Foundation, and the Westreich Foundation. It is important to note that the contribution totals only reflect publicly reported donors and may not include significant contributions from corporations, litigators, and governments. US Right to Know has been involved in controversies surrounding its claims and collaborations, raising questions about the accuracy and reliability of its advocacy efforts.Generated from the website

BioMetis Technology Inc., located in Hayward, California, is a pioneer in AI-powered biotechnology, specializing in AIDME (AI-Directed Molecular Evolution) technology that promotes innovation in synthetic biology. The company focuses on integrated solutions for protein design and genome engineering, catering to various industrial applications, particularly in environmental protection and therapeutics. Established in 2020, BioMetis has made significant advancements in protein engineering and plastic degradation, supported by a growing patent portfolio that underscores its global leadership in the field. Their cutting-edge technology not only addresses pressing challenges in multiple sectors but also emphasizes the creation of sustainable, high-performance enzyme solutions. Generated from the website

The Center for Emerging & Neglected Diseases (CEND) at the University of California, Berkeley, is dedicated to advancing research and development in the areas of immunotherapeutics, vaccine research, and global health diagnostics. Through various initiatives, symposia, and fellowships, CEND aims to address critical health challenges posed by emerging and neglected diseases. CEND fosters collaboration and innovation among faculty, fellows, and partners within the global health community. By leveraging multidisciplinary expertise, the center strives to make significant contributions to public health and the scientific understanding of infectious diseases. Generated from the website